Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
- Type
- Retraction
- Notice date
- 3/22/2022 0:00
- Journal
- Frontiers in Oral Health
- Publisher
- Frontiers
- Notice DOI
- 10.3389/froh.2022.893486
- Original paper DOI
- 10.3389/froh.2021.653104